首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   82039篇
  免费   41790篇
  国内免费   264篇
耳鼻咽喉   1532篇
儿科学   4314篇
妇产科学   679篇
基础医学   16070篇
口腔科学   5139篇
临床医学   12928篇
内科学   23970篇
皮肤病学   7520篇
神经病学   13464篇
特种医学   2377篇
外国民族医学   2篇
外科学   14439篇
综合类   799篇
现状与发展   1篇
一般理论   24篇
预防医学   4525篇
眼科学   1391篇
药学   5958篇
  4篇
中国医学   1241篇
肿瘤学   7716篇
  2024年   26篇
  2023年   132篇
  2022年   276篇
  2021年   1605篇
  2020年   5220篇
  2019年   10962篇
  2018年   10232篇
  2017年   11577篇
  2016年   12182篇
  2015年   12088篇
  2014年   12006篇
  2013年   12527篇
  2012年   4404篇
  2011年   4355篇
  2010年   9132篇
  2009年   5480篇
  2008年   2279篇
  2007年   1132篇
  2006年   1163篇
  2005年   926篇
  2004年   932篇
  2003年   973篇
  2002年   1063篇
  2001年   997篇
  2000年   858篇
  1999年   377篇
  1998年   101篇
  1997年   72篇
  1996年   71篇
  1995年   49篇
  1994年   65篇
  1993年   47篇
  1992年   67篇
  1991年   76篇
  1990年   61篇
  1989年   52篇
  1988年   47篇
  1987年   51篇
  1986年   41篇
  1985年   46篇
  1984年   34篇
  1983年   38篇
  1982年   27篇
  1981年   29篇
  1979年   22篇
  1978年   20篇
  1977年   17篇
  1974年   18篇
  1972年   15篇
  1971年   27篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
T lymphocytes play a fundamental role in the initiation and regulation of chronic inflammatory responses in patients with asthma. CD69 is an early marker of T‐cell activation. The levels of intercellular adhesion molecule‐1 (ICAM‐1, CD54) and L ‐selectin have been reported to increase in patients with allergic diseases and asthma. The present study was therefore undertaken to investigate the expression of CD69, CD54, and L ‐selectin by T lymphocytes of children with asthma, before and after immunotherapy. Eighteen children newly diagnosed with asthma, 11 good and nine poor responders to immunotherapy, and 16 normal subjects, were enrolled in this study. The percentages of CD69+, CD54+, and CD62L+ cells in T lymphocytes were measured by using flow cytometry. The levels of CD69, CD54, and CD62L in serum and culture supernatants were determined by using enzyme‐linked immunosorbent assay (ELISA). The expression of CD69 and CD54 on CD3+ T lymphocytes was significantly higher in children with asthma than in control patients. All the patient groups expressed (spontaneously and following stimulation with phorbol myristate acetate and ionomycin together with mite‐extract proteins) greater amounts of CD69 and CD54 than did control subjects. With long‐term immunotherapy, the percentages of CD69+ and CD54+ T lymphocytes were significantly lower in patients with a good response to immunotherapy. Our results also showed significantly lower serum L ‐selectin levels following immunotherapy. In conclusion, successful immunotherapy resulted in decreased expression and production of CD69 and CD54. These results may explain, in part, the clinical efficacy of immunotherapy.  相似文献   
82.
Reduction mammaplasty by central pedicle flap with short submammary scar   总被引:2,自引:0,他引:2  
Reduction mammaplasty was performed in 30 patients by combining the central pedicle flap method with the short submammary scar (3-S) technique to avoid the common drawbacks of currently popular dermoglandular procedures. Reduction was accomplished by using perforating vascular branches from the pectoralis major muscle and its fascia supplying the nipple and breast parenchyme instead of the subdermal plexus. The central vascular pedicle supplying the nipple-areola complex was preserved. Only the periphery of the breast parenchyme was resected circumferentially, with the exception of the inferolateral portion, so as not to injure the sensory nerve. The remaining breast parenchyme was preserved in an inverted cone shape. The nipple-areola complex was safely transposed with great freedom, and the amount of resection was accurately adjusted for symmetry. No cases of nipple-areola complex sensory change occurred postoperatively, and lactation is possible because of preservation of the lactiferous ducts. The length of postoperative scars was reduced by using the short submammary scar technique. We believe this combined method is ideal in patients requiring resections ranging from 200 to 600 g per breast with good skin elasticity and moderate degree of ptosis.Presented at the Sixth Asian Pacific Congress of the International Confederation for Plastic and Reconstructive Surgery, in Seoul, Korea, October 1993.  相似文献   
83.
84.
目的 快速准确地对可疑病人进行筛选,早期诊断传染性疾病SARS。方法 运用生物信息学这一门数学、统计学、计算机学和生物医学相交融的学科作为研究工具。结果 破解SARS的病原一变异冠状病毒的DNA序列,从而获得SARS冠状病毒全基因组芯片。结论 生物信息学是新世纪跨专业的一门前沿学科。  相似文献   
85.

Background  

This study compared the prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging with that of treadmill exercise score in medically treated patients with coronary artery disease (CAD)  相似文献   
86.
Background: It has been suggested that oral cobalamin (vitamin B12) therapy may be an effective therapy for treating cobalamin deficiencies related to food‐cobalamin malabsorption. However, the duration of this treatment was not determined. Patients and method: In an open‐label, nonplacebo study, we studied 30 patients with established cobalamin deficiency related to food‐cobalamin malabsorption, who received between 250 and 1000 μg of oral crystalline cyanocobalamin per day for at least 1 month. Endpoints: Blood counts, serum cobalamin and homocysteine levels were determined at baseline and during the first month of treatment. Results: During the first month of treatment, 87% of the patients normalized their serum cobalamin levels; 100% increased their serum cobalamin levels (mean increase, +167 pg/dl; P < 0.001 compared with baseline); 100% had evidence of medullary regeneration; 100% corrected their initial macrocytosis; and 54% corrected their anemia. All patients had increased hemoglobin levels (mean increase, +0.6 g/dl) and reticulocyte counts (mean increase, +35 × 106/l) and decreased erythrocyte cell volume (mean decrease, 3 fl; all P < 0.05). Conclusion: Our findings suggest that crystalline cyanocobalamin, 250–1000 μg /day, given orally for 1 month, may be an effective treatment for cobalamin deficiencies not related to pernicious anemia.  相似文献   
87.
叶联顺 《重庆医学》2003,32(6):720-721
目的 本研究用一种经改良的人精子穿卵试验 (SPA)处理人精子 ,以探讨一种更简便、快速、经济 ,适合一般实验室要求的方法。方法 将精子体外获能液用磷酸氢二钠把pH值调理至 8.2± 0 .2 ;用普通隔水式恒温培养箱进行培养 ;对 75例不同生育状态男子生育力进行测定 (其中 2 5例有生育力男子 ;2 5例“原因不明”不育男子 ;及 2 5例输精管吻合术后 )。结果  3种不同生育状态男子的SPA值分别是 (4 7.12± 9.92 ) % ;(2 1.73± 9.91) % ,及 (2 8.0 4± 9.91) %。前两者在统计学上有显著差异 ,(P<0 .0 1) ;后两者在统计学上无明显差异 (P >0 .0 5 )。结果表明经用改良的精子获能液并在普通恒温培养箱培养后精子的活率和活力都有较大的提高 ,这有利于精子的长期获能及提高精子的穿透能力。结论 本研究提示改良后的人精子穿卵试验处理精子确实更简便、快速、经济 ,适合一般实验室要求 ,便于推广。  相似文献   
88.
The objective of this study was to compare the clinical and laboratory consequences of left and right displacement of the abomasum (LDA and RDA), short‐ and long‐term survival after surgery and the findings in cows, that could not be cured by omentopexy. Data from 564 cases of displaced abomasum (466 LDA, 98 RDA) were analysed retrospectively. Clinical and laboratory findings were compared between the two manifestations of DA. Survival was assessed after 10 days and after 15 months. Necropsy was carried out on cows that died or were killed. On arrival at the clinic, left displacement of the abomasum (LDA) cows had been recognized as diseased for longer. LDA occurred earlier in lactation, and more cows with right displacement of the abomasum (RDA) were pregnant. Overall clinical symptoms were more severe in RDA than in LDA cows. Heart rate was higher, body temperature was lower, inanition, abnormal faeces and ruminal stasis were more frequent in RDA cows. Leucocyte counts were higher, and potassium and chloride levels were lower in RDA cows. Acetonuria was more frequent in LDA cows. More LDA than RDA cows were released from the clinic as cured (82.0% versus 74.5%). However, survival after the early post‐surgical period was similar for RDA and LDA cows. At necropsy, diseases of the gastrointestinal system were the predominant finding in RDA cows, while in LDA cows, diseases of the liver and other concurrent diseases were more important.  相似文献   
89.
90.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号